Quantum BioPharma Launches Private Placement for $5 Million

Quantum BioPharma Ltd. has announced a non-brokered private placement aiming to raise up to $5 million through convertible debenture units. The offering price is set at $1,000 per unit, each including a convertible debenture and warrants exercisable for class B shares. The debentures will mature in 36 months, with a 1.25% monthly interest rate.

Investors can convert debentures into class B shares at $6.25 per share. Warrants can be exercised at $7.00 per share over five years. The funds raised will support business development and general expenses. The offering will close in tranches starting the week of December 9, 2024.

Quantum may redeem the debentures before maturity with prior notice and applicable penalties. The offering is restricted to Canadian markets, aligning with regulatory standards.